PHAR
Pharming GroupANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The constructive view is that Joenja is still growing meaningfully despite a messy quarter elsewhere: 1Q26 Joenja revenue rose 34% year over year to $14.1 million, guidance of $405-$425 million was reaffirmed, Japan approval is in hand, EU approval is nearing, and 2H26 PID/CVID readouts offer non-APDS expansion upside [#PR-2026-05-07] [#PR-2026-02-03].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Broader leniolisib PID/CVID expansion is still clinical-stage and could fail to replicate APDS efficacy or regulatory tractability.
Momentum
65
Value
64
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $14.00 · Bull $20.00 · Bear $9.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $32.69
Why
Momentum65 · Δ7d -
Value64 · Δ7d +0.1
Sentiment51 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
65
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
64
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.1
Sentiment
51
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 64.5 / Value 63.9 / Sentiment 51.1
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$928.68M
Beta
-0.24
Shares Out
70.78M
P/E (TTM)
411.2
P/S (TTM)
3.16
P/FCF (TTM)
21.75
Rev YoY
-8.1%
EPS YoY
-65.6%
Gross Margin
+87.3%
Op Margin
+7.3%
Net Debt
-$64.09M
Current Ratio
2.63
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology